Advertisement
Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF (LABU) Stock Competitors & Peer Comparison

See (LABU) competitors and their performances in Stock Market.

LABUAMEX
Financial ServicesAsset Management - Leveraged
$206.86
$6.45(3.22%)
U.S. Market opens in 31h 36m
Advertisement

Peer Comparison Table: Asset Management - Leveraged Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LABU$206.86+3.22%1.1BN/AN/A+0.65%
LACG$7.43-2.04%217.4BN/AN/AN/A
FFEU$90.85+0.48%212.8BN/AN/AN/A
GRAG$6.26+7.67%134.7BN/AN/AN/A
SOXL$278.80+19.22%82B60.04$4.64+0.03%
VTAPX$25.15+0.04%70.5BN/AN/AN/A
VFSTX$10.37+0.10%55.3B15.73$0.66N/A
VFSUX$10.37+0.10%55.3B15.73$0.66N/A
VSBSX$19.38+0.10%33.9BN/AN/AN/A
TQQQ$82.87+6.87%29.8B42.48$1.95+0.38%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LABU vs LACG Comparison June 2026

LABU plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LABU stands at 1.1B. In comparison, LACG has a market cap of 217.4B. Regarding current trading prices, LABU is priced at $206.86, while LACG trades at $7.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LABU currently has a P/E ratio of N/A, whereas LACG's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to LACG's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to LACG. This indicates potentially higher risk in terms of short-term price fluctuations for LABU.Check LACG's competition here

Stock price comparison of stocks in the Financial Services Sector

Loading...

Frequently Asked Questions